Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06423131
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-05-15
Brief Title:
Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT
Sponsor:
Sijia Gu
Organization:
Shanghai Jiao Tong University School of Medicine
Study Overview
Official Title:
TCRαβ Cell Deleted Versus Traditional Haploidentical Hematopoietic Stem Cell Transplantation A Single-center Prospective Non-randomized Controlled Clinical Study
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single-center prospective non-randomized controlled clinical study in China using CliniMACS TCRαβ cell depleted stem cell haploidentical donors versus conventional Beijing protocol for haploidentical hematopoietic stem cell transplantation in children
Detailed Description:
11 non-randomized controlled clinical study in single center using CliniMACS TCRαβ cell depleted stem cell versus conventional Beijing protocol for haploidentical hematopoietic stem cell transplant The purpose of this study is to obtain 30 decrease grade II-IV aGVHD and better qulity of life for TCRαβ cell depleted haploidentical stem cell transplantaion
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None